Hallmarks of cancer: the next generation

Author(s): Hanahan D, Weinberg RA

Abstract

The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.

Similar Articles

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene

Author(s): Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, et al.

Defective autophagy leads to cancer

Author(s): Edinger AL, Thompson CB

Induction of autophagy and inhibition of tumorigenesis by beclin 1

Author(s): Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, et al.

Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours

Author(s): Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, et al.

Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma

Author(s): Daniel F, Legrand A, Pessayre D, Borrega-Pires F, Mbida L, et al.

Beclin 1 gene inhibits tumor growth in colon cancer cell lines

Author(s): Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A

Role of autophagy in cancer

Author(s): Mathew R, Karantza-Wadsworth V, White E

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

Author(s): Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, et al.

Autophagy is a therapeutic target in anticancer drug resistance

Author(s): Chen S, Rehman SK, Zhang W, Wen A, Yao L, et al.

Tissue transglutaminase inhibits autophagy in pancreatic cancer cells

Author(s): Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, et al.

Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes

Author(s): Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, et al.

Autophagy triggered by magnolol derivative negatively regulates angiogenesis

Author(s): Kumar S, Guru SK, Pathania AS, Kumar A, Bhushan S, et al.

Pancreatic cancer biology and genetics

Author(s): Bardeesy N, DePinho RA

Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

Author(s): Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, et al.

The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells

Author(s): Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, et al.